NCT01673074View on ClinicalTrials.gov

HPPH and PDT for Pleural Malignancy

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 31, 2013

Study Completion Date

October 8, 2014

Conditions
Pleural Malignancy
Interventions
DRUG

(PDT) Photodynamic therapy

photosensitizer

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT01673074 - HPPH and PDT for Pleural Malignancy | Biotech Hunter | Biotech Hunter